Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Barrett

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Current Eye Research|January 1, 1992
Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein, phosducinH S Dua, R H Lee, R N Lolley, et al.
Bioconjugate Chemistry|March 1, 1996
Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugatesJ A Barrett, D J Damphousse, S J Heminway, et al.
Epidemiology (Cambridge, Mass.)|March 1, 1991
Hip fracture incidence and mortality in New EnglandE S Fisher, J A Baron, D J Malenka, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1986
Results of venous reconstruction after civilian vascular traumaA R Pasch, R A Bishara, J J Schuler, et al.
Bioconjugate Chemistry|January 1, 1996
Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligandsS Liu, D S Edwards, R J Looby, et al.
Nuclear Medicine Communications|February 24, 2001
A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbitsA H Brouwers, P Laverman, O C Boerman, et al.
Bioconjugate Chemistry|March 1, 1997
New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcD S Edwards, S Liu, J A Barrett, et al.
Blood|December 12, 2001
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndromeJ P Maciejewski, D Follmann, R Nakamura, et al.
Molecular Ecology|September 26, 2002
Polyploidy, phylogeography and Pleistocene refugia of the rockfern Asplenium ceterach: evidence from chloroplast DNAS A Trewick, M Morgan-Richards, S J Russell, et al.
The Journal of Trauma|December 1, 1989
Toxicology screening in urban trauma patients: drug prevalence and its relationship to trauma severity and managementE P Sloan, R J Zalenski, R F Smith, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Current Eye Research|January 1, 1992
Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein, phosducinH S Dua, R H Lee, R N Lolley, et al.
Bioconjugate Chemistry|March 1, 1996
Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugatesJ A Barrett, D J Damphousse, S J Heminway, et al.
Epidemiology (Cambridge, Mass.)|March 1, 1991
Hip fracture incidence and mortality in New EnglandE S Fisher, J A Baron, D J Malenka, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1986
Results of venous reconstruction after civilian vascular traumaA R Pasch, R A Bishara, J J Schuler, et al.
Bioconjugate Chemistry|January 1, 1996
Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligandsS Liu, D S Edwards, R J Looby, et al.
Nuclear Medicine Communications|February 24, 2001
A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbitsA H Brouwers, P Laverman, O C Boerman, et al.
Bioconjugate Chemistry|March 1, 1997
New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcD S Edwards, S Liu, J A Barrett, et al.
Blood|December 12, 2001
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndromeJ P Maciejewski, D Follmann, R Nakamura, et al.
Molecular Ecology|September 26, 2002
Polyploidy, phylogeography and Pleistocene refugia of the rockfern Asplenium ceterach: evidence from chloroplast DNAS A Trewick, M Morgan-Richards, S J Russell, et al.
The Journal of Trauma|December 1, 1989
Toxicology screening in urban trauma patients: drug prevalence and its relationship to trauma severity and managementE P Sloan, R J Zalenski, R F Smith, et al.
Pageof 12